BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 10758440)

  • 1. Dolasetron for the prevention of postoperative nausea and vomiting following outpatient surgery with general anaesthesia: a randomized, placebo-controlled study. The Dolasetron PONV Prevention Study Group.
    Philip BK; Pearman MH; Kovac AL; Chelly JE; Wetchler BV; McKenzie R; Monk TG; Dershwitz M; Mingus M; Sung YF; Hahne WF; Brown RA
    Eur J Anaesthesiol; 2000 Jan; 17(1):23-32. PubMed ID: 10758440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pooled analysis of three large clinical trials to determine the optimal dose of dolasetron mesylate needed to prevent postoperative nausea and vomiting. The Dolasetron Prophylaxis Study Group.
    Philip BK; McLeskey CH; Chelly JE; McKenzie R; Kovac AL; Diemunsch P; DuBois DM
    J Clin Anesth; 2000 Feb; 12(1):1-8. PubMed ID: 10773500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of postoperative nausea and vomiting with single intravenous doses of dolasetron mesylate: a multicenter trial. Dolasetron Mesylate PONV Treatment Study Group.
    Kovac AL; Scuderi PE; Boerner TF; Chelly JE; Goldberg ME; Hantler CB; Hahne WF; Brown RA
    Anesth Analg; 1997 Sep; 85(3):546-52. PubMed ID: 9296407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral dolasetron mesylate for prevention of postoperative nausea and vomiting: a multicenter, double-blind, placebo-controlled study. The Oral Dolasetron PONV Prevention Study Group.
    Diemunsch P; Korttila K; Leeser J; Helmers JH; Wilkey B; Navé S; Radke AJ; Hahne WF; Brown RA
    J Clin Anesth; 1998 Mar; 10(2):145-52. PubMed ID: 9524901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postoperative nausea and vomiting after surgery for prognathism: not only a question of patients' comfort. A placebo-controlled comparison of dolasetron and droperidol.
    Piper SN; Röhm K; Boldt J; Kranke P; Maleck W; Seifert R; Suttner S
    J Craniomaxillofac Surg; 2008 Apr; 36(3):173-179. PubMed ID: 18353666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prophylaxis of nausea and vomiting after thyroid surgery: comparison of oral and intravenous dolasetron with intravenous droperidol and placebo].
    Danner K; Becker HG; Best B; Madler C
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2001 Jul; 36(7):425-30. PubMed ID: 11496617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous dolasetron and ondansetron in prevention of postoperative nausea and vomiting: a multicenter, double-blind, placebo-controlled study.
    Korttila K; Clergue F; Leeser J; Feiss P; Olthoff D; Payeur-Michel C; Wessel P; Nave S; Hahne W; Brown R
    Acta Anaesthesiol Scand; 1997 Aug; 41(7):914-22. PubMed ID: 9265937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of prophylactic dolasetron or droperidol vs rescue therapy in the prevention of PONV in ambulatory gynecologic surgery.
    Frighetto L; Loewen PS; Dolman J; Marra CA
    Can J Anaesth; 1999 Jun; 46(6):536-43. PubMed ID: 10391600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous dolasetron for the prevention of postoperative nausea and vomiting after outpatient laparoscopic gynecologic surgery.
    Graczyk SG; McKenzie R; Kallar S; Hickok CB; Melson T; Morrill B; Hahne WF; Brown RA
    Anesth Analg; 1997 Feb; 84(2):325-30. PubMed ID: 9024022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Dolasetron, droperidol and a combination of both in prevention of postoperative nausea and vomiting after extracapsular cataract extraction under general anesthesia].
    Eberhart LH; Lindenthal M; Seeling W; Gäckle H; Georgieff M
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1999 Jun; 34(6):345-9. PubMed ID: 10429772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous dolasetron mesilate in the prevention of postoperative nausea and vomiting in females undergoing gynecological surgery.
    Diemunsch P; D'Hollander A; Paxton L; Schoeffler P; Wessel P; Navé S; Brown RA; Hahne WF
    J Clin Anesth; 1997 Aug; 9(5):365-73. PubMed ID: 9257201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double-blind, placebo-controlled trial of i.v. dolasetron mesilate in the prevention of radiotherapy-induced nausea and vomiting in cancer patients.
    Bey P; Wilkinson PM; Resbeut M; Bourdin S; Le Floch O; Hahne W; Claverie N
    Support Care Cancer; 1996 Sep; 4(5):378-83. PubMed ID: 8883232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of timing of dolasetron administration on its efficacy as a prophylactic antiemetic in the ambulatory setting.
    Chen X; Tang J; White PF; Wender RH; Quon R; Sloninsky A; Naruse R; Kariger R; Webb T; Norel E
    Anesth Analg; 2001 Oct; 93(4):906-11. PubMed ID: 11574355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of oral dolasetron and ondansetron in the prophylaxis of postoperative nausea and vomiting in children.
    Karamanlioglu B; Turan A; Memis D; Süt N
    Eur J Anaesthesiol; 2003 Oct; 20(10):831-5. PubMed ID: 14580054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prevention of post-operative nausea and vomiting. Randomised comparison of dolasetron versus dolasetron plus dexamethasone].
    Piper SN; Triem JG; Röhm KD; Kranke P; Maleck WH; Boldt J
    Anaesthesist; 2003 Feb; 52(2):120-6. PubMed ID: 12624696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Timing of administration of dolasetron affects dose necessary to prevent postoperative nausea and vomiting.
    Korttila KT; Jokinen JD
    J Clin Anesth; 2004 Aug; 16(5):364-70. PubMed ID: 15374558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A double-blind, multicentre comparison of intravenous dolasetron mesilate and metoclopramide in the prevention of nausea and vomiting in cancer patients receiving high-dose cisplatin chemotherapy.
    Chevallier B; Cappelaere P; Splinter T; Fabbro M; Wendling JL; Cals L; Catimel G; Giovannini M; Khayat D; Bastit P; Claverie N
    Support Care Cancer; 1997 Jan; 5(1):22-30. PubMed ID: 9010986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous dolasetron mesilate ameliorates postoperative nausea and vomiting.
    Diemunsch P; Leeser J; Feiss P; D'Hollander A; Bradburn BG; Paxton D; Whitmore J; Panouillot P; Navé S; Brown RA; Hahne WF
    Can J Anaesth; 1997 Feb; 44(2):173-81. PubMed ID: 9043731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of single-dose intravenous dolasetron versus ondansetron in the prevention of postoperative nausea and vomiting.
    Walker JB
    Clin Ther; 2001 Jun; 23(6):932-8. PubMed ID: 11440292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double-blind, randomised, parallel study comparing intravenous dolasetron plus dexamethasone and intravenous dolasetron alone for the management of fractionated cisplatin-related nausea and vomiting.
    Fauser AA; Pizzocaro G; Schueller J; Khayat D; Wilkinson P
    Support Care Cancer; 2000 Jan; 8(1):49-54. PubMed ID: 10650898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.